[
  {
    "text": "<p>New funding applications are referred to one of Pharmac's Funding Application Advisors (FAAs), who'll review the application to ensure they have the relevant information to undertake a preliminary analysis.&nbsp; They may seek more information if required.</p>\r\n<p><a class=\"external-link\" href=\"https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/new-funding-applications/\" rel=\"nofollow\">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/new-funding-applications/</a></p>",
    "position": 0,
    "name": "Application Received",
    "last": false,
    "events": [
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "May 2003",
          "fs": "May 2003",
          "change": null
        },
        "Event_Description": {
          "s": "Application received",
          "fs": "Application received",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P000006hZK0UAM"
          },
          "Id": "a0P2P000006hZK0UAM",
          "Event_Date__c": "2003-05-08",
          "Event_Description__c": "Application received",
          "Stage__c": "Application Received",
          "Formatted_Date__c": "May 2003",
          "Status_History__c": "a132P000000AovSQAS"
        },
        "change": null
      }
    ],
    "dateString": "May 2003",
    "collapsed": false,
    "checked": true
  },
  {
    "text": "<p>Pharmac is identifying and gathering information required to get clinical advice.  The <a class=\"external-link\" href=\"https://pharmac.govt.nz/about/expert-advice/pharmacology-and-therapeutics-advisory-committee-ptac/\" rel=\"nofollow\">Pharmacology and Therapeutics Advisory Committee (PTAC)</a>  meets quarterly. There are also around 20 expert <a class=\"external-link\" href=\"https://pharmac.govt.nz/about/expert-advice/specialist-advisory-committees/\" rel=\"nofollow\">Specialist Advisory Committees (SACs)</a>, previously expert Subcommittees, which provide clinical evaluations in specialist areas. Specialist Advisory Committees meet as required to discuss issues referred to them by PTAC or Pharmac.</p>\n<p style=\"height: 20px\">&nbsp;</p>\n<p>In November 2021, we introduced separate terms of reference for the SACs to make clear that these committees have different, but complementary, roles, expertise and perspectives to PTAC.</p>\n<p style=\"height: 15px\">&nbsp;</p>\n<p>PTAC and SACs may make recommendations to Pharmac that differ from each other when looking at the same evidence. Pharmac considers the recommendations provided by all our clinical advisory committees when assessing applications.</p>\n<p style=\"height: 20px\">&nbsp;</p>\n<p><a class=\"external-link\" href=\"https://pharmac.govt.nz/about/expert-advice/pharmacology-and-therapeutics-advisory-committee-ptac/ptac-terms-of-reference-july-2021/\" rel=\"nofollow\">PTAC</a>  and <a class=\"external-link\" href=\"https://pharmac.govt.nz/about/expert-advice/specialist-advisory-committees/specialist-advisory-committee-terms-of-reference//\" rel=\"nofollow\">Specialist Advisory Committees</a> records of the meeting will be published on this website in accordance with the Terms of Reference.</p>",
    "position": 1,
    "name": "Seeking Clinical Advice",
    "last": false,
    "events": [
      {
        "Summary": {
          "s": "&#39;The Subcommittee noted that this product was intended to assist in wound healing, in particular from ulcers.  The Subcommittee considered that the nutritional assistance offered by this product could be obtained from normal dietary measures.  The Subcommittee considered that it would be difficult to enforce the targeting of this product to specific patient groups.    The Subcommittee recommended that the application to list Cubitan on the Pharmaceutical Schedule be declined.&#39;",
          "fs": "&#39;The Subcommittee noted that this product was intended to assist in wound healing, in particular from ulcers.  The Subcommittee considered that the nutritional assistance offered by this product could be obtained from normal dietary measures.  The Subcommittee considered that it would be difficult to enforce the targeting of this product to specific patient groups.    The Subcommittee recommended that the application to list Cubitan on the Pharmaceutical Schedule be declined.&#39;",
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": "Decline",
          "fs": "Decline",
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Oct 2003",
          "fs": "Oct 2003",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice received from Special Foods Subcommittee at meeting Wednesday 1 October 2003.",
          "fs": "Clinical advice received from Special Foods Subcommittee at meeting Wednesday 1 October 2003.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P000006hZK1UAM"
          },
          "Id": "a0P2P000006hZK1UAM",
          "Event_Date__c": "2003-10-01",
          "Event_Description__c": "Clinical advice received from Special Foods Subcommittee at meeting Wednesday 1 October 2003.",
          "Stage__c": "Seeking Clinical Advice",
          "Outcome__c": "Decline",
          "Summary__c": "&#39;The Subcommittee noted that this product was intended to assist in wound healing, in particular from ulcers.  The Subcommittee considered that the nutritional assistance offered by this product could be obtained from normal dietary measures.  The Subcommittee considered that it would be difficult to enforce the targeting of this product to specific patient groups.    The Subcommittee recommended that the application to list Cubitan on the Pharmaceutical Schedule be declined.&#39;",
          "Formatted_Date__c": "Oct 2003",
          "Status_History__c": "a132P000000AowWQAS"
        },
        "change": null
      },
      {
        "Summary": {
          "s": "Referred to the Special Foods Subcommittee.",
          "fs": "Referred to the Special Foods Subcommittee.",
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Dec 2013",
          "fs": "Dec 2013",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice required",
          "fs": "Clinical advice required",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P000006hZK5UAM"
          },
          "Id": "a0P2P000006hZK5UAM",
          "Event_Date__c": "2013-12-05",
          "Event_Description__c": "Clinical advice required",
          "Stage__c": "Seeking Clinical Advice",
          "Summary__c": "Referred to the Special Foods Subcommittee.",
          "Formatted_Date__c": "Dec 2013",
          "Status_History__c": "a132P000000AqYhQAK"
        },
        "change": null
      },
      {
        "Summary": {
          "s": "Deferred pending review of the Cereda et al (2013) paper and pending advice from the Dermatology Subcommittee of PTAC.",
          "fs": "Deferred pending review of the Cereda et al (2013) paper and pending advice from the Dermatology Subcommittee of PTAC.",
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": "Deferred",
          "fs": "Deferred",
          "change": null
        },
        "Links": {
          "s": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-special-foods-subcommittee-minutes-2014-02.pdf\" target=\"_blank\">Special Foods Subcommittee minutes</a>",
          "fs": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-special-foods-subcommittee-minutes-2014-02.pdf\" target=\"_blank\">Special Foods Subcommittee minutes</a>",
          "change": null
        },
        "Formatted_Date": {
          "s": "Dec 2013",
          "fs": "Dec 2013",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice received from Special Foods Subcommittee at meeting Thursday 5 December 2013.",
          "fs": "Clinical advice received from Special Foods Subcommittee at meeting Thursday 5 December 2013.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P000006hZK6UAM"
          },
          "Id": "a0P2P000006hZK6UAM",
          "Event_Date__c": "2013-12-05",
          "Event_Description__c": "Clinical advice received from Special Foods Subcommittee at meeting Thursday 5 December 2013.",
          "Stage__c": "Seeking Clinical Advice",
          "Links__c": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-special-foods-subcommittee-minutes-2014-02.pdf\" target=\"_blank\">Special Foods Subcommittee minutes</a>",
          "Outcome__c": "Deferred",
          "Summary__c": "Deferred pending review of the Cereda et al (2013) paper and pending advice from the Dermatology Subcommittee of PTAC.",
          "Formatted_Date__c": "Dec 2013",
          "Status_History__c": "a132P000000AqYkQAK"
        },
        "change": null
      },
      {
        "Summary": {
          "s": "The Dermatological Subcommittee provided information to assist the Special Foods Subcommittee in making a recommendation.",
          "fs": "The Dermatological Subcommittee provided information to assist the Special Foods Subcommittee in making a recommendation.",
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": "These minutes have been ratified by the Pharmacology and Therapeutic Advisory Committee.",
          "fs": "These minutes have been ratified by the Pharmacology and Therapeutic Advisory Committee.",
          "change": null
        },
        "Outcome": {
          "s": "No Formal Recommendation",
          "fs": "No Formal Recommendation",
          "change": null
        },
        "Links": {
          "s": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-dermatology-subcommittee-minutes-2013-12.pdf\" target=\"_blank\">Dermatology Subcommittee minutes</a>",
          "fs": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-dermatology-subcommittee-minutes-2013-12.pdf\" target=\"_blank\">Dermatology Subcommittee minutes</a>",
          "change": null
        },
        "Formatted_Date": {
          "s": "Dec 2013",
          "fs": "Dec 2013",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice received from Dermatology Subcommittee at meeting Monday 9 December 2013.",
          "fs": "Clinical advice received from Dermatology Subcommittee at meeting Monday 9 December 2013.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P000006hZK7UAM"
          },
          "Id": "a0P2P000006hZK7UAM",
          "Event_Date__c": "2013-12-09",
          "Event_Description__c": "Clinical advice received from Dermatology Subcommittee at meeting Monday 9 December 2013.",
          "Stage__c": "Seeking Clinical Advice",
          "Links__c": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-dermatology-subcommittee-minutes-2013-12.pdf\" target=\"_blank\">Dermatology Subcommittee minutes</a>",
          "Outcome__c": "No Formal Recommendation",
          "Summary__c": "The Dermatological Subcommittee provided information to assist the Special Foods Subcommittee in making a recommendation.",
          "Formatted_Date__c": "Dec 2013",
          "PTAC_Comments__c": "These minutes have been ratified by the Pharmacology and Therapeutic Advisory Committee.",
          "Status_History__c": "a132P000000AqZfQAK"
        },
        "change": null
      },
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": "Deferred",
          "fs": "Deferred",
          "change": null
        },
        "Links": {
          "s": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-minutes-2014-05.pdf\" target=\"_blank\">PTAC minutes</a>",
          "fs": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-minutes-2014-05.pdf\" target=\"_blank\">PTAC minutes</a>",
          "change": null
        },
        "Formatted_Date": {
          "s": "May 2014",
          "fs": "May 2014",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 8 May 2014.",
          "fs": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 8 May 2014.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P000006hZK8UAM"
          },
          "Id": "a0P2P000006hZK8UAM",
          "Event_Date__c": "2014-05-08",
          "Event_Description__c": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 8 May 2014.",
          "Stage__c": "Seeking Clinical Advice",
          "Links__c": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-minutes-2014-05.pdf\" target=\"_blank\">PTAC minutes</a>",
          "Outcome__c": "Deferred",
          "Formatted_Date__c": "May 2014",
          "Status_History__c": "a132P000000AqgPQAS"
        },
        "change": null
      },
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": "Deferred",
          "fs": "Deferred",
          "change": null
        },
        "Links": {
          "s": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-special-foods-subcommittee-minutes-2015-07.pdf\" target=\"_blank\">Special Foods Subcommittee minutes</a>",
          "fs": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-special-foods-subcommittee-minutes-2015-07.pdf\" target=\"_blank\">Special Foods Subcommittee minutes</a>",
          "change": null
        },
        "Formatted_Date": {
          "s": "Jul 2015",
          "fs": "Jul 2015",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice received from Special Foods Subcommittee at meeting Wednesday 22 July 2015.",
          "fs": "Clinical advice received from Special Foods Subcommittee at meeting Wednesday 22 July 2015.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P000006hZK9UAM"
          },
          "Id": "a0P2P000006hZK9UAM",
          "Event_Date__c": "2015-07-22",
          "Event_Description__c": "Clinical advice received from Special Foods Subcommittee at meeting Wednesday 22 July 2015.",
          "Stage__c": "Seeking Clinical Advice",
          "Links__c": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-special-foods-subcommittee-minutes-2015-07.pdf\" target=\"_blank\">Special Foods Subcommittee minutes</a>",
          "Outcome__c": "Deferred",
          "Formatted_Date__c": "Jul 2015",
          "Status_History__c": "a132P000000AqxNQAS"
        },
        "change": null
      },
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Jan 2016",
          "fs": "Jan 2016",
          "change": null
        },
        "Event_Description": {
          "s": "PHARMAC awaits the publication of certain peer reviewed clinical data before it will continue to examine this application.",
          "fs": "PHARMAC awaits the publication of certain peer reviewed clinical data before it will continue to examine this application.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P000006hZKAUA2"
          },
          "Id": "a0P2P000006hZKAUA2",
          "Event_Date__c": "2016-01-06",
          "Event_Description__c": "PHARMAC awaits the publication of certain peer reviewed clinical data before it will continue to examine this application.",
          "Stage__c": "Seeking Clinical Advice",
          "Formatted_Date__c": "Jan 2016",
          "Status_History__c": "a132P000000Ar3bQAC"
        },
        "change": null
      },
      {
        "Summary": {
          "s": "<p><span style=\"font-family: Arial, sans-serif; font-size: 11pt;\">The Special Food Subcommittee of PTAC recommended that this application be declined at its meeting in December 2017.</span></p>",
          "fs": "<p><span style=\"font-family: Arial, sans-serif; font-size: 11pt;\">The Special Food Subcommittee of PTAC recommended that this application be declined at its meeting in December 2017.</span></p>",
          "change": null
        },
        "Published_Recommendation": {
          "s": "<p>The Subcommittee recommended that the revised funding application for Cubitan to aid in the recovery of pressure ulcers be declined.\u00a0</p>",
          "fs": "<p>The Subcommittee recommended that the revised funding application for Cubitan to aid in the recovery of pressure ulcers be declined.\u00a0</p>",
          "change": null
        },
        "Published_Discussion": {
          "s": "<p>The Subcommittee noted a review made by the Dermatology Subcommittee at its December 2017 meeting of Cubitan and the resubmitted evidence requested. Members noted that the Dermatology Subcommittee recommended that the application be declined and considered that the evidence reviewed did not show a significant clinical benefit for an arginine-rich supplement in the treatment of PU above that already available in New Zealand.</p><p><br></p><p>The Subcommittee noted that Cubitan is a ready-to-drink nutritional supplement with high levels of arginine, zinc, vitamin C and other components considered to aid in the recovery of pressure ulcers (PU). The Subcommittee considered Cubitan is not nutritionally complete and not intended as a supplement to treat malnutrition.</p><p><br></p><p>The Subcommittee considered the results of Cereda et al (Ann Intern Med. 2015;162:167- 74), a randomised controlled trial in seven centres of Cubitan versus a similar nutritional product with less arginine, zinc and antioxidants in patients with pressure ulcers who were malnourished. \u2022 The Subcommittee agreed with the Dermatology Subcommittee assessment of the trial and considered that the exclusion criteria for the study removed many patients in New Zealand who would experience pressure ulcers.</p><p><br></p><p>The Subcommittee considered the results of an economic evaluation by the same authors of the Cereda et al. 2015 RCT. This study compared cost effectiveness and direct medical costs of local PU care (Cereda et al. Clinical Nutrition. 2017;36(1):246-52). \u2022 The Subcommittee agreed with the Dermatology Subcommittee evaluation and considered that the evidence was of low quality and modest benefit. Members considered that it would be challenging to apply this to the New Zealand setting.</p><p><br></p><p>The Subcommittee considered a systematic review to assess the effect of arginineenriched enteral formulas in PU healing (Liu et al. J Wound Care. 2017; 26: 319-23). This review included seven RCTs and 369 patients, four of which assessed healing by PU area reduction.19 \u2022 The Subcommittee agreed with the Dermatology Subcommittee evaluation and considered that the findings would need to be supported by large sample RCTs with consistent outcomes and reporting.</p><p><br></p><p>The Subcommittee considered that Arginine is widespread in food and in line with a \u2018food first\u2019 approach considered that good nutrition heals pressure ulcers. Members considered that there is no evidence provided that indicates that Cubitan or arginine rich foods are any better at healing pressure ulcers than good nutrition.</p>",
          "fs": "<p>The Subcommittee noted a review made by the Dermatology Subcommittee at its December 2017 meeting of Cubitan and the resubmitted evidence requested. Members noted that the Dermatology Subcommittee recommended that the application be declined and considered that the evidence reviewed did not show a significant clinical benefit for an arginine-rich supplement in the treatment of PU above that already available in New Zealand.</p><p><br></p><p>The Subcommittee noted that Cubitan is a ready-to-drink nutritional supplement with high levels of arginine, zinc, vitamin C and other components considered to aid in the recovery of pressure ulcers (PU). The Subcommittee considered Cubitan is not nutritionally complete and not intended as a supplement to treat malnutrition.</p><p><br></p><p>The Subcommittee considered the results of Cereda et al (Ann Intern Med. 2015;162:167- 74), a randomised controlled trial in seven centres of Cubitan versus a similar nutritional product with less arginine, zinc and antioxidants in patients with pressure ulcers who were malnourished. \u2022 The Subcommittee agreed with the Dermatology Subcommittee assessment of the trial and considered that the exclusion criteria for the study removed many patients in New Zealand who would experience pressure ulcers.</p><p><br></p><p>The Subcommittee considered the results of an economic evaluation by the same authors of the Cereda et al. 2015 RCT. This study compared cost effectiveness and direct medical costs of local PU care (Cereda et al. Clinical Nutrition. 2017;36(1):246-52). \u2022 The Subcommittee agreed with the Dermatology Subcommittee evaluation and considered that the evidence was of low quality and modest benefit. Members considered that it would be challenging to apply this to the New Zealand setting.</p><p><br></p><p>The Subcommittee considered a systematic review to assess the effect of arginineenriched enteral formulas in PU healing (Liu et al. J Wound Care. 2017; 26: 319-23). This review included seven RCTs and 369 patients, four of which assessed healing by PU area reduction.19 \u2022 The Subcommittee agreed with the Dermatology Subcommittee evaluation and considered that the findings would need to be supported by large sample RCTs with consistent outcomes and reporting.</p><p><br></p><p>The Subcommittee considered that Arginine is widespread in food and in line with a \u2018food first\u2019 approach considered that good nutrition heals pressure ulcers. Members considered that there is no evidence provided that indicates that Cubitan or arginine rich foods are any better at healing pressure ulcers than good nutrition.</p>",
          "change": null
        },
        "Published_Application": {
          "s": "<p>The Subcommittee reviewed a second funding application from a supplier to review the widening of access of Cubitan, a nutritional supplement to aid in the recovery of pressure ulcers (PU).</p><p><br></p><p>The Subcommittee noted that this application was reviewed by the Special Foods Subcommittee and the Dermatology Subcommittee in December 2013. Both Subcommittees considered that the evidence for use in pressure ulcers was weak in quality and strength, and a recommendation was deferred until a published study (Cereda et al. Ann Intern Med. 2015;162:167-74) was made available for review.</p>",
          "fs": "<p>The Subcommittee reviewed a second funding application from a supplier to review the widening of access of Cubitan, a nutritional supplement to aid in the recovery of pressure ulcers (PU).</p><p><br></p><p>The Subcommittee noted that this application was reviewed by the Special Foods Subcommittee and the Dermatology Subcommittee in December 2013. Both Subcommittees considered that the evidence for use in pressure ulcers was weak in quality and strength, and a recommendation was deferred until a published study (Cereda et al. Ann Intern Med. 2015;162:167-74) was made available for review.</p>",
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": "Decline",
          "fs": "Decline",
          "change": null
        },
        "Links": {
          "s": "<p><a href=\"https://pharmac.govt.nz/assets/ptac-special-foods-subcommittee-minutes-2017-12.pdf\" target=\"_blank\">Special Foods Subcommittee minutes</a></p>",
          "fs": "<p><a href=\"https://pharmac.govt.nz/assets/ptac-special-foods-subcommittee-minutes-2017-12.pdf\" target=\"_blank\">Special Foods Subcommittee minutes</a></p>",
          "change": null
        },
        "Formatted_Date": {
          "s": "Dec 2017",
          "fs": "Dec 2017",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice received from Special Foods Subcommittee at meeting Thursday 7 December 2017.",
          "fs": "Clinical advice received from Special Foods Subcommittee at meeting Thursday 7 December 2017.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P000006hZKBUA2"
          },
          "Id": "a0P2P000006hZKBUA2",
          "Event_Date__c": "2017-12-07",
          "Event_Description__c": "Clinical advice received from Special Foods Subcommittee at meeting Thursday 7 December 2017.",
          "Stage__c": "Seeking Clinical Advice",
          "Links__c": "<p><a href=\"https://pharmac.govt.nz/assets/ptac-special-foods-subcommittee-minutes-2017-12.pdf\" target=\"_blank\">Special Foods Subcommittee minutes</a></p>",
          "Outcome__c": "Decline",
          "Summary__c": "<p><span style=\"font-family: Arial, sans-serif; font-size: 11pt;\">The Special Food Subcommittee of PTAC recommended that this application be declined at its meeting in December 2017.</span></p>",
          "Formatted_Date__c": "Dec 2017",
          "Published_Recommendation__c": "<p>The Subcommittee recommended that the revised funding application for Cubitan to aid in the recovery of pressure ulcers be declined.\u00a0</p>",
          "Published_Application__c": "<p>The Subcommittee reviewed a second funding application from a supplier to review the widening of access of Cubitan, a nutritional supplement to aid in the recovery of pressure ulcers (PU).</p><p><br></p><p>The Subcommittee noted that this application was reviewed by the Special Foods Subcommittee and the Dermatology Subcommittee in December 2013. Both Subcommittees considered that the evidence for use in pressure ulcers was weak in quality and strength, and a recommendation was deferred until a published study (Cereda et al. Ann Intern Med. 2015;162:167-74) was made available for review.</p>",
          "Published_Discussion__c": "<p>The Subcommittee noted a review made by the Dermatology Subcommittee at its December 2017 meeting of Cubitan and the resubmitted evidence requested. Members noted that the Dermatology Subcommittee recommended that the application be declined and considered that the evidence reviewed did not show a significant clinical benefit for an arginine-rich supplement in the treatment of PU above that already available in New Zealand.</p><p><br></p><p>The Subcommittee noted that Cubitan is a ready-to-drink nutritional supplement with high levels of arginine, zinc, vitamin C and other components considered to aid in the recovery of pressure ulcers (PU). The Subcommittee considered Cubitan is not nutritionally complete and not intended as a supplement to treat malnutrition.</p><p><br></p><p>The Subcommittee considered the results of Cereda et al (Ann Intern Med. 2015;162:167- 74), a randomised controlled trial in seven centres of Cubitan versus a similar nutritional product with less arginine, zinc and antioxidants in patients with pressure ulcers who were malnourished. \u2022 The Subcommittee agreed with the Dermatology Subcommittee assessment of the trial and considered that the exclusion criteria for the study removed many patients in New Zealand who would experience pressure ulcers.</p><p><br></p><p>The Subcommittee considered the results of an economic evaluation by the same authors of the Cereda et al. 2015 RCT. This study compared cost effectiveness and direct medical costs of local PU care (Cereda et al. Clinical Nutrition. 2017;36(1):246-52). \u2022 The Subcommittee agreed with the Dermatology Subcommittee evaluation and considered that the evidence was of low quality and modest benefit. Members considered that it would be challenging to apply this to the New Zealand setting.</p><p><br></p><p>The Subcommittee considered a systematic review to assess the effect of arginineenriched enteral formulas in PU healing (Liu et al. J Wound Care. 2017; 26: 319-23). This review included seven RCTs and 369 patients, four of which assessed healing by PU area reduction.19 \u2022 The Subcommittee agreed with the Dermatology Subcommittee evaluation and considered that the findings would need to be supported by large sample RCTs with consistent outcomes and reporting.</p><p><br></p><p>The Subcommittee considered that Arginine is widespread in food and in line with a \u2018food first\u2019 approach considered that good nutrition heals pressure ulcers. Members considered that there is no evidence provided that indicates that Cubitan or arginine rich foods are any better at healing pressure ulcers than good nutrition.</p>",
          "Status_History__c": "a132P000000ArOEQA0"
        },
        "change": null
      }
    ],
    "dateString": "Oct 2003",
    "collapsed": false,
    "checked": true
  },
  {
    "text": "<p>Following Clinical Advice, Pharmac staff considers the advice and the funding application under goes an assessment using our&nbsp;<a class=\"external-link\" href=\"https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/factors-for-consideration/\" rel=\"nofollow\">Factors for Consideration</a>&nbsp;framework and seeks additional information as required.</p>\r\n<p>&nbsp;</p>\r\n<p>Research and Economic analysis are undertaken.&nbsp; This focuses on the costs and benefits of a proposed course of action. Economics is based on three fundamental concepts that summarise the issues Pharmac faces daily:&nbsp;</p>\r\n<ul>\r\n<li>Scarcity &ndash; resources will always be insufficient to support all possible activities.</li>\r\n<li>Choices &ndash; due to scarce resources, decisions must be made about how best to use them.</li>\r\n<li>Opportunity cost &ndash; by choosing to use resources one way, we forgo other opportunities to use the same resources.</li>\r\n</ul>\r\n<p>&nbsp;</p>\r\n<p>For further information on the purpose of, and techniques for, undertaking economic analysis in health care, please refer&nbsp;<a class=\"external-link\" href=\"https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/economic-analysis/\" rel=\"nofollow\">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/economic-analysis/</a></p>",
    "position": 2,
    "name": "Under Assessment",
    "last": false,
    "events": [
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "May 2021",
          "fs": "May 2021",
          "change": null
        },
        "Event_Description": {
          "s": "Working to compare options",
          "fs": "Working to compare options",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P000006hZKCUA2"
          },
          "Id": "a0P2P000006hZKCUA2",
          "Event_Date__c": "2021-05-03",
          "Event_Description__c": "Working to compare options",
          "Stage__c": "Under Assessment",
          "Formatted_Date__c": "May 2021",
          "Status_History__c": "a132P000000CoWVQA0"
        },
        "change": null
      }
    ],
    "dateString": "May 2021",
    "collapsed": false,
    "checked": true
  },
  {
    "text": "<p>Pharmac staff uses a prioritisation process to compare and rank funding options. Possible opportunities for new investment will always exceed the budget Pharmac has available; therefore, prioritisation is an intrinsic part of Pharmac\u2019s decision-making process.</p>\r\n<p>The relative ranking of options aims to support Pharmac&rsquo;s statutory objective &ldquo;to secure for eligible people in need of pharmaceuticals, the best health outcomes that are reasonably achievable from pharmaceutical treatment and from within the amount of funding provided&rdquo;.</p>\r\n<p>A funding application or proposal is considered ready for prioritisation when sufficient information is available to permit it to be reviewed against Pharmac's Factors for Consideration and to inform a comparison with other possible investment decisions.</p>\r\n<p>There is no guarantee when or if a ranked medicine will be funded.&nbsp;&nbsp;<a class=\"external-link\" href=\"https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/prioritisation/\" rel=\"nofollow\">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/prioritisation/</a></p>",
    "position": 3,
    "name": "Options Compared",
    "last": false,
    "events": [
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "May 2021",
          "fs": "May 2021",
          "change": null
        },
        "Event_Description": {
          "s": "The relative ranking of the pharmaceutical application has been completed.",
          "fs": "The relative ranking of the pharmaceutical application has been completed.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P000006hZKDUA2"
          },
          "Id": "a0P2P000006hZKDUA2",
          "Event_Date__c": "2021-05-27",
          "Event_Description__c": "The relative ranking of the pharmaceutical application has been completed.",
          "Stage__c": "Options Compared",
          "Formatted_Date__c": "May 2021",
          "Status_History__c": "a132P000000CsgAQAS"
        },
        "change": null
      }
    ],
    "dateString": "May 2021",
    "collapsed": false,
    "checked": true
  },
  {
    "text": "<p>Pharmac is consulting on a proposal to either approve or decline the application.&nbsp;We seek the views of all people who have an interest in our proposals, or who may be affected by them, to obtain feedback on our proposed approaches.</p>\r\n<p><a class=\"external-link\" href=\"https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/having-your-say/\" rel=\"nofollow\">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/having-your-say/</a></p>",
    "position": 4,
    "name": "Under Consultation",
    "last": false,
    "events": [
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Mar 2004",
          "fs": "Mar 2004",
          "change": null
        },
        "Event_Description": {
          "s": "Public consultation for this application is active.",
          "fs": "Public consultation for this application is active.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P000006hZK2UAM"
          },
          "Id": "a0P2P000006hZK2UAM",
          "Event_Date__c": "2004-03-24",
          "Event_Description__c": "Public consultation for this application is active.",
          "Stage__c": "Under Consultation",
          "Formatted_Date__c": "Mar 2004",
          "Status_History__c": "a132P000000AoyiQAC"
        },
        "change": null
      },
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": "<p><a href=\"https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/2021-06-29-proposal-to-decline-inactive-funding-applications\" target=\"_blank\" style=\"background-color: rgb(255, 255, 255);\">https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/2021-06-29-proposal-to-decline-inactive-funding-applications</a></p>",
          "fs": "<p><a href=\"https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/2021-06-29-proposal-to-decline-inactive-funding-applications\" target=\"_blank\" style=\"background-color: rgb(255, 255, 255);\">https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/2021-06-29-proposal-to-decline-inactive-funding-applications</a></p>",
          "change": null
        },
        "Formatted_Date": {
          "s": "Jun 2021",
          "fs": "Jun 2021",
          "change": null
        },
        "Event_Description": {
          "s": "Public consultation for this application is active.",
          "fs": "Public consultation for this application is active.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P000006hZKEUA2"
          },
          "Id": "a0P2P000006hZKEUA2",
          "Event_Date__c": "2021-06-28",
          "Event_Description__c": "Public consultation for this application is active.",
          "Stage__c": "Under Consultation",
          "Links__c": "<p><a href=\"https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/2021-06-29-proposal-to-decline-inactive-funding-applications\" target=\"_blank\" style=\"background-color: rgb(255, 255, 255);\">https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/2021-06-29-proposal-to-decline-inactive-funding-applications</a></p>",
          "Formatted_Date__c": "Jun 2021",
          "Status_History__c": "a132P000000CxdSQAS"
        },
        "change": null
      }
    ],
    "dateString": "Mar 2004",
    "collapsed": false,
    "checked": true
  },
  {
    "text": "<p>Following the consultation process, Pharmac staff considers the feedback and identifies any additional information required as part of a gap analysis.&nbsp; The proposal may require further clinical advice, research, and assessment.</p>",
    "position": 5,
    "name": "Reviewing Consultation Feedback",
    "last": false,
    "events": [
      {
        "Summary": {
          "s": "The consultation letter proposed to decline the application to list Cubitan.",
          "fs": "The consultation letter proposed to decline the application to list Cubitan.",
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Apr 2004",
          "fs": "Apr 2004",
          "change": null
        },
        "Event_Description": {
          "s": "Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.",
          "fs": "Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P000006hZK3UAM"
          },
          "Id": "a0P2P000006hZK3UAM",
          "Event_Date__c": "2004-04-16",
          "Event_Description__c": "Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.",
          "Stage__c": "Reviewing Consultation Feedback",
          "Summary__c": "The consultation letter proposed to decline the application to list Cubitan.",
          "Formatted_Date__c": "Apr 2004",
          "Status_History__c": "a132P000000Aoz8QAC"
        },
        "change": null
      },
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Sep 2013",
          "fs": "Sep 2013",
          "change": null
        },
        "Event_Description": {
          "s": "Received Additional Information",
          "fs": "Received Additional Information",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P000006hZK4UAM"
          },
          "Id": "a0P2P000006hZK4UAM",
          "Event_Date__c": "2013-09-01",
          "Event_Description__c": "Received Additional Information",
          "Stage__c": "Reviewing Consultation Feedback",
          "Formatted_Date__c": "Sep 2013",
          "Status_History__c": "a132P000000AqSrQAK"
        },
        "change": null
      },
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Aug 2021",
          "fs": "Aug 2021",
          "change": null
        },
        "Event_Description": {
          "s": "Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.",
          "fs": "Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P000006hZKFUA2"
          },
          "Id": "a0P2P000006hZKFUA2",
          "Event_Date__c": "2021-08-02",
          "Event_Description__c": "Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.",
          "Stage__c": "Reviewing Consultation Feedback",
          "Formatted_Date__c": "Aug 2021",
          "Status_History__c": "a132P000000D3sIQAS"
        },
        "change": null
      }
    ],
    "dateString": "Apr 2004",
    "collapsed": false,
    "checked": true
  },
  {
    "text": "<p>We refer to our decisions about whether and how particular pharmaceuticals are publicly-funded, as &ldquo;funding decisions&rdquo;.</p>\r\n<p>We consider and assess all funding decisions using the&nbsp;<a class=\"external-link\" href=\"https://www.pharmac.govt.nz/about/operating-policies-and-procedures/#factorsfc\" rel=\"nofollow\">Factors for Consideration</a>. When we do so, we carefully evaluate clinical and other evidence for the benefits and suitability of a proposal, and to identify and understand the people who will be affected by it.</p>\r\n<p>While our main task is to allocate pharmaceutical funding, we consider the benefits and costs across the whole health system now and with a long-term focus, including the effects for hospitals and primary care, and consider direct costs to patients as well as to all health sector budgets.</p>\r\n<p>Final funding decisions are made by the Pharmac Board or delegated to senior Pharmac staff as required by the Board.</p>\r\n<p>&nbsp;</p>",
    "position": 6,
    "name": "Decision",
    "last": true,
    "events": [
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": "<p><a href=\"https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/decision-2022-03-08-inactive-declines/\" target=\"_blank\">Notification letter</a></p>",
          "fs": "<p><a href=\"https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/decision-2022-03-08-inactive-declines/\" target=\"_blank\">Notification letter</a></p>",
          "change": null
        },
        "Formatted_Date": {
          "s": "Feb 2022",
          "fs": "Feb 2022",
          "change": null
        },
        "Event_Description": {
          "s": "The funding application has been declined.",
          "fs": "The funding application has been declined.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P000006hZKGUA2"
          },
          "Id": "a0P2P000006hZKGUA2",
          "Event_Date__c": "2022-02-04",
          "Event_Description__c": "The funding application has been declined.",
          "Stage__c": "Decision",
          "Links__c": "<p><a href=\"https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/decision-2022-03-08-inactive-declines/\" target=\"_blank\">Notification letter</a></p>",
          "Formatted_Date__c": "Feb 2022",
          "Status_History__c": "a132P000000DaqiQAC"
        },
        "change": null
      }
    ],
    "dateString": "Feb 2022",
    "collapsed": false,
    "checked": true
  }
]